This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Dr. Aron Tendler, CMO of Brainsway®, is interviewed on Deep TMS as a treatment option for depression, as well as the conncetions between depresison and ADD. Listen to the interview here.